Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-20-002328
Accepted
2020-09-02 00:15:16
Documents
1
Effectiveness Date
2020-09-01
Registration Form
POS AM
Reference AccNo
0001437749-20-018885

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 615
  Complete submission text file 9999999995-20-002328.txt   1844
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-238911 | Film No.: 201155621
SIC: 2835 In Vitro & In Vivo Diagnostic Substances